These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 26826416

  • 21. Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays.
    Kenmotsu H, Serizawa M, Koh Y, Isaka M, Takahashi T, Taira T, Ono A, Maniwa T, Takahashi S, Mori K, Endo M, Abe M, Hayashi I, Nakajima T, Ohde Y, Yamamoto N.
    BMC Cancer; 2014 Oct 28; 14():786. PubMed ID: 25348872
    [Abstract] [Full Text] [Related]

  • 22. Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?
    Vincenten JP, Smit EF, Grünberg K, Postmus PE, Snijders PJ, Witte BI, Heideman DA, Thunnissen E.
    Lung Cancer; 2015 Jul 28; 89(1):19-26. PubMed ID: 25982011
    [Abstract] [Full Text] [Related]

  • 23. p40 & thyroid transcription factor-1 immunohistochemistry: A useful panel to characterize non-small cell lung carcinoma-not otherwise specified (NSCLC-NOS) category.
    Walia R, Jain D, Madan K, Sharma MC, Mathur SR, Mohan A, Iyer VK, Kumar L.
    Indian J Med Res; 2017 Jul 28; 146(1):42-48. PubMed ID: 29168459
    [Abstract] [Full Text] [Related]

  • 24. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
    Allison DB, Lilo MT, Geddes S, Pallavajjalla A, Askin F, Gabrielson E, Zheng G, Li QK.
    Cancer Cytopathol; 2016 Jul 28; 124(7):485-92. PubMed ID: 27007084
    [Abstract] [Full Text] [Related]

  • 25. Inflammatory Giant Cell Carcinoma of the Lung: Clinicopathologic, Immunohistochemical, and Next-generation Sequencing Study of 14 Cases.
    Suster DI, Mackinnon AC, Ronen N, Mejbel HA, Harada S, Michal M, Suster S.
    Am J Surg Pathol; 2024 Oct 01; 48(10):1215-1223. PubMed ID: 38989701
    [Abstract] [Full Text] [Related]

  • 26. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
    Pelosi G, Rossi G, Cavazza A, Righi L, Maisonneuve P, Barbareschi M, Graziano P, Pastorino U, Garassino M, de Braud F, Papotti M.
    Int J Surg Pathol; 2013 Jun 01; 21(3):229-39. PubMed ID: 23486764
    [Abstract] [Full Text] [Related]

  • 27. Roles of immunohistochemical staining in diagnosing pulmonary squamous cell carcinoma.
    Yan Y, Zhang YX, Fang WF, Kang SY, Zhan JH, Chen N, Hong SD, Liang WH, Tang YN, He DC, Wu X, Zhang L.
    Asian Pac J Cancer Prev; 2015 Jun 01; 16(2):551-7. PubMed ID: 25684486
    [Abstract] [Full Text] [Related]

  • 28. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
    Kadota K, Nitadori J, Rekhtman N, Jones DR, Adusumilli PS, Travis WD.
    Am J Surg Pathol; 2015 Sep 01; 39(9):1170-80. PubMed ID: 25871623
    [Abstract] [Full Text] [Related]

  • 29. Biomarker expression and druggable gene alterations for development of an appropriate therapeutic protocol for pulmonary adenosquamous carcinoma.
    Watanabe Y, Shiraishi K, Takahashi F, Yoshida A, Suzuki K, Asamura H, Takeuchi M, Furuta K, Tsuta K.
    Histopathology; 2015 Jun 01; 66(7):939-48. PubMed ID: 25257380
    [Abstract] [Full Text] [Related]

  • 30. [Precision medical treatment of non-adenocarcinoma NSCLC patients with EGFR mutation].
    Wang ZH, Song XY.
    Zhonghua Zhong Liu Za Zhi; 2017 Feb 23; 39(2):90-93. PubMed ID: 28219201
    [Abstract] [Full Text] [Related]

  • 31. Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
    Alhamar M, Tudor Vladislav I, Smith SC, Gao Y, Cheng L, Favazza LA, Alani AM, Ittmann MM, Riddle ND, Whiteley LJ, Gupta NS, Carskadon S, Gomez-Gelvez JC, Chitale DA, Palanisamy N, Hes O, Trpkov K, Williamson SR.
    Histopathology; 2020 Dec 23; 77(6):890-899. PubMed ID: 32639612
    [Abstract] [Full Text] [Related]

  • 32. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
    Lim SM, Kim EY, Kim HR, Ali SM, Greenbowe JR, Shim HS, Chang H, Lim S, Paik S, Cho BC.
    Oncotarget; 2016 Apr 26; 7(17):24172-8. PubMed ID: 26992220
    [Abstract] [Full Text] [Related]

  • 33. Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung.
    Vieira T, Antoine M, Ruppert AM, Fallet V, Duruisseaux M, Giroux Leprieur E, Poulot V, Rabbe N, Sclick L, Beau-Faller M, Lacave R, Lavole A, Cadranel J, Wislez M.
    Lung Cancer; 2014 Aug 26; 85(2):276-81. PubMed ID: 24997135
    [Abstract] [Full Text] [Related]

  • 34. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
    Kawai T, Tominaga S, Hiroi S, Kameda K, Ogata S, Nakashima H, Ozeki Y, Nakanishi K.
    Acta Cytol; 2015 Aug 26; 59(6):457-64. PubMed ID: 26696549
    [Abstract] [Full Text] [Related]

  • 35. Cribriform adenocarcinoma of the lung: clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma.
    Mackinnon AC, Luevano A, de Araujo LC, Rao N, Le M, Suster S.
    Mod Pathol; 2014 Aug 26; 27(8):1063-72. PubMed ID: 24390215
    [Abstract] [Full Text] [Related]

  • 36. MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.
    Song Z, Wang X, Zheng Y, Su H, Zhang Y.
    Clin Lung Cancer; 2017 Mar 26; 18(2):213-219.e2. PubMed ID: 28322191
    [Abstract] [Full Text] [Related]

  • 37. Emerging Biomarkers in Personalized Therapy of Lung Cancer.
    Cagle PT, Raparia K, Portier BP.
    Adv Exp Med Biol; 2016 Mar 26; 890():25-36. PubMed ID: 26703797
    [Abstract] [Full Text] [Related]

  • 38. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
    Preusser M, Berghoff AS, Koller R, Zielinski CC, Hainfellner JA, Liebmann-Reindl S, Popitsch N, Geier CB, Streubel B, Birner P.
    Eur J Cancer; 2015 Sep 26; 51(13):1803-11. PubMed ID: 26164066
    [Abstract] [Full Text] [Related]

  • 39. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
    Ohtsuka K, Ohnishi H, Fujiwara M, Kishino T, Matsushima S, Furuyashiki G, Takei H, Koshiishi Y, Goya T, Watanabe T.
    Cancer; 2007 Feb 15; 109(4):741-50. PubMed ID: 17238183
    [Abstract] [Full Text] [Related]

  • 40. Comprehensive analysis of oncogenic mutations in lung squamous cell carcinoma with minor glandular component.
    Pan Y, Wang R, Ye T, Li C, Hu H, Yu Y, Zhang Y, Wang L, Luo X, Li H, Li Y, Shen L, Sun Y, Chen H.
    Chest; 2014 Mar 01; 145(3):473-479. PubMed ID: 24158231
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.